Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Focus Point Holdings BhdXKLS:0157 69 Return-on-Tangible-Equity is 23.80% as of Mar. 2026, which is 32% above its 10-year median of 18.04. GuruFocus rates XKLS:0157 with a GF Score™ of 69/100 and a GF Value™ of RM0.67 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 760 Medical Devices & Instruments companies, Focus Point Holdings Bhd ranks better than 86.18% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Focus Point Holdings Bhd's annualized net income for the quarter that ended in Mar. 2026 was RM36.8 Mil. Focus Point Holdings Bhd's average shareholder tangible equity for the quarter that ended in Mar. 2026 was RM154.6 Mil. Therefore, Focus Point Holdings Bhd's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 23.80%.
The historical rank and industry rank for Focus Point Holdings Bhd's Return-on-Tangible-Equity or its related term are showing as below:
XKLS:0157'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -2.24 Med: 18.04 Max: 40.41
Current: 24.38
During the past 13 years, Focus Point Holdings Bhd's highest Return-on-Tangible-Equity was 40.41%. The lowest was -2.24%. And the median was 18.04%.
XKLS:0157's Return-on-Tangible-Equity is ranked better than 86.18% of 760
companies
in the Medical Devices & Instruments industry
Industry Median: 4.03
vs XKLS:0157: 24.38
Focus Point Holdings Bhd (XKLS:0157) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Focus Point Holdings Bhd Return-on-Tangible-Equity Related Terms
Focus Point Holdings Bhd Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Focus Point Holdings Bhd's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Focus Point Holdings Bhd Return-on-Tangible-Equity Chart
XKLS:0157 vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Focus Point Holdings Bhd's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Focus Point Holdings Bhd Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Focus Point Holdings Bhd's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Focus Point Holdings Bhd's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 23.80% mean?
Focus Point Holdings Bhd (XKLS:0157) has a Return-on-Tangible-Equity of 23.80% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Focus Point Holdings Bhd and its competitors. This is 32% above median its historical median of 18.04. According to the industry distribution chart, Focus Point Holdings Bhd ranks #105 out of 760 companies in the Medical Devices & Instruments industry, placing it in the top 13.8%.
Is Focus Point Holdings Bhd's Return-on-Tangible-Equity too high?
Focus Point Holdings Bhd's current Return-on-Tangible-Equity of 23.80% is 32% above median its 10-year median of 18.04. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.03. Focus Point Holdings Bhd's value of 23.80% is 490.6% above this industry median. Based on the distribution chart, Focus Point Holdings Bhd ranks #105 out of 760 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Focus Point Holdings Bhd has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Focus Point Holdings Bhd's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Focus Point Holdings Bhd ranks #105 out of 760 companies for Return-on-Tangible-Equity. This places Focus Point Holdings Bhd in the top 14% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.03. Focus Point Holdings Bhd's value of 23.80% is 490.6% above this benchmark. While the company's 10-year median is 18.04 vs. the industry median of 4.03, Focus Point Holdings Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.03, based on 760 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Focus Point Holdings Bhd's current Return-on-Tangible-Equity of 23.80% is 490.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Focus Point Holdings Bhd and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Focus Point Holdings Bhd's current Return-on-Tangible-Equity is 23.80%, which is 32% above median its own 10-year median of 18.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Focus Point Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Focus Point Holdings Bhd (XKLS:0157) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.67, compared to a current price of RM0.51 — trading 24.6% below its estimated fair value. The current Return-on-Tangible-Equity is 23.80%, which is 32% above median its 10-year median of 18.04 and 490.6% above the Medical Devices & Instruments industry median of 4.03. Focus Point Holdings Bhd's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Focus Point Holdings Bhd (XKLS:0157), the current Return-on-Tangible-Equity is 23.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Focus Point Holdings Bhd (XKLS:0157) Overvalued in 2026?
Based on GuruFocus' analysis, Focus Point Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.51 is trading 24.6% below its estimated GF Value™ of RM0.67.
GuruFocus considers Focus Point Holdings Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0157:
Return-on-Tangible-Equity: 23.80% (32% above median its 10-year median of 18.04)
GF Value™: RM0.67 vs. price of RM0.51 (24.6% below fair value)
Industry Position: 490.6% above the Medical Devices & Instruments median (#105 of 760)
No single metric tells the full story. See the XKLS:0157 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Focus Point Holdings Bhd operates professional eye care centres, trading of eyewear and eye care products, investment holding, retail sale of other food products, management of franchised professional eye care centres, provision of medical eye care services, and operation of food and beverages business. The company's operating segments are the Optical segment and the Food and Beverages segment. The firm generates the majority of its revenue from the Optical segment, which is engaged in the retailing of optical and related products, including the management of franchised optical outlets. The food and beverages segment is into the provision of food and beverage services, including the management of franchised food and beverage outlets.
69GF Score
Get the complete analysis for XKLS:0157
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0157 has been successfully added to your 
